ScanBalt Business Portrait: Oslo Cancer Cluster
Oslo Cancer Cluster is a non-profit member organization dedicated to accelerate the development of new cancer diagnostics and medicines through: Local collaboration and international partnerships; Stimulation and support of new innovations and start-up activities; strengthening of our member’s ability to attract capital; Improved clinical trial efficiency for our members; Increase of governmental focus and improved public policies for the cancer community, fostering and attracting the next generation of top talents to cancer R&D and entrepreneurship.
In June 2007, the cluster became a Norwegian Centre of Expertise (NCE). Oslo Cancer Cluster has more than 70 members from Northern Europe, representing the entire oncology value chain from bench to bedside.
ScanBalt News
3 September 2024
LSX Nordic Congress 2024 | 8-9 October | Copenhagen, Denmark